Cysteine

Cysteine

SCHEMBL21747580

CC(C)=O.NC(CS)C(=O)O

nearest known ligand 0.84

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 2/20 0.84
SLC7A11 Q9UPY5 1/20 0.84
SLC7A5 Q01650 2/20 0.48
GRIK1 P39086 5/20 0.46
ENPEP Q07075 4/20 0.46
SLC1A3 P43003 5/20 0.43
SLC1A2 P43004 5/20 0.43
SLC1A1 P43005 4/20 0.43
ALOX15 P16050 2/20 0.43
BLM P54132 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MAPT P10636 1/20 0.43
THRB P10828 1/20 0.43
NFKB1 P19838 1/20 0.43
PTGS2 P35354 1/20 0.43
THPO P40225 1/20 0.43
RECQL P46063 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
GRIK2 Q13002 4/20 0.42
GRM8 O00222 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cysteine SCHEMBL27613026 0.95 PTGS1 (0.84) PTGS1SLC7A11SLC7A5GRIK1ENPEP
Cysteine SCHEMBL1848591 0.92 PTGS1 (0.80) PTGS1SLC7A11SLC7A5GRIK1ENPEP
Cysteine SCHEMBL6112869 0.92 PTGS1 (0.80) PTGS1SLC7A11SLC7A5GRIK1ENPEP
Cysteine SCHEMBL6112867 0.92 PTGS1 (0.80) PTGS1SLC7A11SLC7A5GRIK1ENPEP
Cysteine SCHEMBL6244297 0.92 PTGS1 (0.80) PTGS1SLC7A11SLC7A5GRIK1ENPEP
Cysteine SCHEMBL28253736 0.92 PTGS1 (0.80) PTGS1SLC7A11SLC7A5GRIK1ENPEP
Cysteine SCHEMBL1275659 0.92 PTGS1 (0.80) PTGS1SLC7A11SLC7A5GRIK1ENPEP
Cysteine SCHEMBL6244287 0.92 PTGS1 (0.80) PTGS1SLC7A11SLC7A5GRIK1ENPEP
Cysteine SCHEMBL17315768 0.92
Cysteine SCHEMBL17315767 0.92

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112638934-B Solution phase Path for WNT hexapeptide 温特研究公司 2024-06-11 CN disclosed
US-11970551-B2 Solution phase routes for WNT hexapeptides WNTRESEARCH AB (SE) 2024-04-30 US disclosed
US-11912791-B2 Solution phase routes for Wnt hexapeptides WNTRESEARCH AB (SE) 2024-02-27 US disclosed
US-20230295232-A1 SOLUTION PHASE ROUTES FOR WNT HEXAPEPTIDES WNTRESEARCH AB (SE) 2023-09-21 US disclosed
EP-3841107-A1 SOLUTION PHASE ROUTES FOR WNT HEXAPEPTIDES Wntresearch AB (SE) 2021-06-30 EP disclosed
US-20210171575-A1 SOLUTION PHASE ROUTES FOR WNT HEXAPEPTIDES WNTRESEARCH AB (SE) 2021-06-10 US disclosed
CN-112638934-A Solution phase route for WNT hexapeptides 温特研究公司 2021-04-09 CN disclosed
WO-2020038878-A1 SOLUTION PHASE ROUTES FOR WNT HEXAPEPTIDES WNTRESEARCH AB (SE) 2020-02-27 WO disclosed
EP-3613757-A1 SOLUTION PHASE ROUTES FOR WNT HEXAPEPTIDES Wntresearch AB (SE) 2020-02-26 EP disclosed